Dr. Imran Unal, MD

Dr. Unal practices at University of Maryland Medical Center Midtown Campus in Baltimore, Maryland, part of University of Maryland Medical System.

Dr. Unal's NPI, 1538540950, was assigned on June 11, 2015. Dr. Unal holds Pennsylvania license MD472912.

Dr. Unal's primary practice is University of Maryland Medical Center Midtown Campus, at 827 Linden Avenue, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 225-8996.

Dr. Unal's primary practice is University of Maryland Medical Center Midtown Campus in Baltimore, Maryland, part of University of Maryland Medical System. Dr. Unal is also affiliated with Christiana Hospital. The medical group on file is University of Maryland Medical Center Gastroenterology and Hepatology. Dmand AI also links Dr. Unal to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Unal practices, 3 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Unal's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Unal is licensed in Pennsylvania.

CMS data shows 526 Medicare services from Dr. Unal across 5 procedure codes in 2024, for 274 Medicare patients. Medicare paid $38,921 for them.

CMS counts 274 Medicare patients who saw Dr. Unal in 2024. The largest group is 65 to 74, with 120 patients. 75% of them have diabetes, and 75% have high blood pressure. 30% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Unal's median patient age at 52, with 65% women.

In 2024, Dr. Unal wrote 372 Medicare Part D claims for 80 patients. 30% of them were for generic drugs. CMS names the drug for 216 of them, across 12 drugs with 11 or more claims each, at $208,318 in total drug cost. In 2023, CMS named 81 claims across 4 drugs.

Dr. Unal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Unal as offering telehealth.

CMS Open Payments shows 3 general payments to Dr. Unal from 3 drug and device companies from 2017 to 2023. Food and beverage make up the largest share, 76% of the total. Valeant Pharmaceuticals International paid the most, $21.